Is this you? Create Your Porfile
Avatar

Nicola Frances Bateman

AstraZeneca

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Nicola Frances Bateman is active.

Explore More

Publication

Featured researches published by Nicola Frances Bateman.

Archive | 2002

Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp

Julie Kay Cahill; Nicola Frances Bateman

Archive | 2002

Pharmaceutical formulation comprising (r) -bicalutamide

Nicola Frances Bateman; Julie Kay Cahill

Archive | 2002

Solid pharmaceutical composition comprising 4-cyano-trifluoro-3-(4-fluorophenyl sulphonyl)-2-hydroxy-2-methylpropiono- m toluidide, pvp, an anti-oestrogen and/or an aromatase inhibitor

Nicola Frances Bateman; Julie Kay Cahill; Neill Hugh Carman; Ian Derek Cockshott

Archive | 2009

Pharmaceutical composition 271

Nicola Frances Bateman; Paul Richard Gellert; Kathryn Jane Hill

Archive | 2009

Pharmaceutical depot comprising n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide

Nicola Frances Bateman; Philip A. MacFaul; Ian Alun Nash

Archive | 2017

formulação farmacêutica, compreendendo n-{5-[(ciclopropilamino)carbonil]-2-metilfenil}-3-fuoro-4-(piridin-2-ilmetóxi)benzamida

Ian Alun Nash; Nicola Frances Bateman; Philip A. MacFaul

Archive | 2010

Sustained-release composition comprising compound 600

Nicola Frances Bateman; Philip A. MacFaul; Ian Alun Nash

Archive | 2010

Compositions comprising an oxoisoquinoline methylbenzamide and a polymer

Nicola Frances Bateman; Anne Elizabeth Cooper; Paul Alfred Dickinson; Philip A. MacFaul; Ian Alun Nash; Steven Swallow

Archive | 2009

Composition pharmaceutique 271

Nicola Frances Bateman; Paul Richard Gellert; Kathryn Jane Hill

Archive | 2009

Stable compositions of the hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3h-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide

Nicola Frances Bateman; Paul Richard Gellert; Kathryn Jane Hill

Explore More

Collaboration

Dive into the Nicola Frances Bateman's collaboration.

Top Co-Authors
Avatar

Ian Alun Nash

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Julie Kay Cahill

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Kathryn Jane Hill

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Paul Richard Gellert

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Philip A. MacFaul

AstraZeneca

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge